[HTML][HTML] Cost-effectiveness analysis of PEG-rhG-CSF as primary prophylaxis to chemotherapy-induced neutropenia in women with breast cancer in China: Results …
J Zhao, G Qiao, Y Liang, J Li, W Hu, X Zuo… - Frontiers in …, 2022 - frontiersin.org
Background: Pegylated recombinant human granulocyte colony-stimulating factors (PEG-
rhG-CSFs) are more commonly and widely used than recombinant human granulocyte …
rhG-CSFs) are more commonly and widely used than recombinant human granulocyte …
Real-World Impact of Prophylactic Growth Factor Use on Timing of Febrile Neutropenia and Infection After High-Risk Chemotherapy
DW Blayney, NM Kuderer, AKC Joyner, J Jarvis… - Journal of the National …, 2023 - jnccn.org
Background: Prophylactic growth-factor therapy with granulocyte colony-stimulating factor (G-
CSF) reduces the risk of febrile neutropenia (FN) in patients with breast cancer initiating …
CSF) reduces the risk of febrile neutropenia (FN) in patients with breast cancer initiating …
Role of biosimilar pegfilgrastim in the treatment of febrile neutropenia: A Mini Review
S Shahab, S Ahmad - Indian Journal of Biochemistry and Biophysics …, 2024 - or.niscpr.res.in
Biologics have no true generics due to their complex nature but biosimilars offer a hopeful
alternative. Biosimilars are similar to biologics as tested with comparable safety and efficacy …
alternative. Biosimilars are similar to biologics as tested with comparable safety and efficacy …
[HTML][HTML] Febrile neutropenia prophylaxis, G-CSF physician preferences: discrete-choice experiment
F Scotte, H Simon, P Laplaige, EC Antoine… - BMJ Supportive & …, 2021 - spcare.bmj.com
Objectives Febrile neutropenia (FN) commonly occurs during cancer chemotherapy.
Prophylaxis with granulocyte colony-stimulating factors (G-CSFs) is known to reduce the …
Prophylaxis with granulocyte colony-stimulating factors (G-CSFs) is known to reduce the …
[HTML][HTML] The Real-World Experience of the Biosimilar (Grastofil®) to the Reference Biologic (Neupogen®) in Breast Cancer and Lymphoma: A Canadian Single …
G Wong, K Wang, M Pasetka, L Zhang, J Lou… - Current …, 2022 - mdpi.com
Febrile neutropenia (FN) is a common side effect of cytotoxic chemotherapy that may result
in poor treatment outcomes. The short acting granulocyte colony stimulating factors (G-CSF) …
in poor treatment outcomes. The short acting granulocyte colony stimulating factors (G-CSF) …